| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 151 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 135 |
| 2 | TACROLIMUS OINTMENT 0.1% | 135 |
| 3 | MYCOPHENOLATE MOFETIL | 124 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 124 |
| 5 | PREDNISONE | 99 |
| 6 | BASILIXIMAB | 56 |
| 7 | PREDNISOLONE | 40 |
| 8 | PREDNISOLONE ORAL | 40 |
| 9 | PREDNISOLONE ORAL SOLUTION | 40 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERYTHROMYCIN LACTOBIONATE | 2 | 0.0135 |
| 1 | BASILIXIMAB | 56 | 0.0047 |
| 2 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 2 | 0.0041 |
| 3 | ERAVACYCLINE | 1 | 0.0034 |
| 4 | BELATACEPT | 8 | 0.0017 |
| 5 | GANCICLOVIR SODIUM | 14 | 0.0013 |
| 6 | VALGANCICLOVIR | 21 | 0.0011 |
| 7 | TACROLIMUS OINTMENT 0.1% | 135 | 0.0011 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 135 | 0.0011 |
| 9 | ISAVUCONAZONIUM SULFATE | 4 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 8 | 0.0017 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 25 | 0.0011 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 3 | 0.0009 |
| 4 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 2 | 0.0008 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 17 | 0.0008 |
| 6 | Interferon gamma [EPC] | 1 | 0.0007 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 7 | 0.0005 |
| 8 | Human Immunoglobulin G [EPC] | 11 | 0.0005 |
| 9 | Penem Antibacterial [EPC] | 15 | 0.0004 |